CD274 and neoplasm: Studies have shown that radiotherapy not only upregulates PD-L1 expression on tumor cell surfaces but also modulates the expression of various immune checkpoint ligands, including PD-L1, on immune cells within the tumor microenvironment, generating an immunosuppressive antitumor effect (Du et al., 2022; Wu et al., 2023).